Navigation Links
Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President
Date:8/22/2011

CHADDS FORD, Pa., Aug. 22, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of Kelly Huang, Ph.D., to the position of President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, an Endo subsidiary, is a leading U.S. provider of urological products and services based in Austin, Texas.

Huang will take over leadership from current HealthTronics Group President James Whittenburg, who is staying through the remainder of the year to effect a seamless transition as HealthTronics continues to provide exceptional urological products and services in improving patient care. Whittenburg joined HealthTronics in 2004, was appointed President and CEO in 2007 and became an Endo Group President in July 2010 with the acquisition of HealthTronics, Inc.

Prior to joining HealthTronics, Dr. Huang held the role of Vice President of Research & Development at Neutrogena, where he was also a member of the global Management Board.  Prior to Neutrogena, Dr. Huang established and headed the Molsaic Internal Venture, a startup sponsored by Johnson & Johnson's Development Corporation. Prior to Molsaic, Dr. Huang held leadership positions within Johnson & Johnson's Consumer business, which included spending two years in Paris, France, that drove innovation globally.

"I am very pleased to announce Kelly's appointment to lead our important HealthTronics subsidiary," said David Holveck, president and chief executive officer of Endo Pharmaceuticals. "Kelly brings a wealth of experience leading global businesses through the integration of scientific, consumer and professional insights and creating value by putting the customer and patient at the center. Kelly's experiences and skills will be invaluable to Endo's continued transformation to provide integrated healthcare solutions to patients, payers and providers, as well as Healt
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
2. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
3. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
4. Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol
5. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
6. Access Pharmaceuticals Provides Second Quarter Update on MuGard Commercial Activities
7. Janssen Pharmaceuticals, Inc. Launches Online Tools on PrescribeResponsibly.com
8. Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results
9. Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
10. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
11. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 A global ... hypertension, diabetes and thyroid disorders in Latin ... a major conference dedicated to these diseases. ... Online , Manage Hypertension Online and ... by EXCEMED - combine the world,s top ...
(Date:7/3/2015)...  Obsidian HDS, the developer of PharmaShine ( ... management of data on pharmaceutical and device industry payments ... the 2014 Open Payments General and Research data released ... The data disclosed on Open Payments for 2014 includes ... totaling $6.49 billion and is the largest public disclosure ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... N.J., Jan. 3, 2011 The U.S. Food and ... to include a 200 mg formulation of INTELENCE ® ... for the treatment of human immunodeficiency virus (HIV-1) in ... antiretroviral (ARV) agents.   The recommended oral ...
... 2011 Henry Schein, Inc. (Nasdaq: HSIC ... services to office-based practitioners, today announced it has completed ... closing conditions have been met, including approval of the ... Provet Holdings is Australasia,s largest wholesale distributor of ...
Cached Medicine Technology:FDA Approves New Dosage Strength for INTELENCE® 2FDA Approves New Dosage Strength for INTELENCE® 3FDA Approves New Dosage Strength for INTELENCE® 4FDA Approves New Dosage Strength for INTELENCE® 5Henry Schein Completes Acquisition of Provet Holdings Limited 2Henry Schein Completes Acquisition of Provet Holdings Limited 3Henry Schein Completes Acquisition of Provet Holdings Limited 4
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Dr. Lawrence ... Washington, DC, area patients. Kybella is a non-surgical method to dissolve fat ... of reducing moderate to severe fat deposits under the chin, commonly known as a ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The ... Hospital in Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, Senior ... patients and adult day center participants. , The Music & Memory program is committed ... families and volunteers. Music & Memory is a non-profit organization that helps provide patients ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... ... ancillary benefits market, is excited to announce the next generation of PrimeStar Individual ... Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and usual, ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in ... in Lake Orion. These classes are geared towards families that want their children ... break. , The fitness class will take place TUESDAYS at 4:30pm. Questions? ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... University in US are offering new insight into how ... ,Research from Brandeis University, which has been ... much needed insights into the probable shaping of the ... have provided new evidence towards the mechanisms that affect ...
... only when they affect only the diseased organs or cells ... to direct microcapsules into cancer cells and release their contents ... in releasing a substance into the tumour cell. They did ... directing it into the tumour cells where it gets “unpacked” ...
... improve quality of care, say researchers in this ... recently recommended //certification of doctors to strengthen professional ... in the United States that allows doctors to ... standards required for licensing purposes. Certified status must ...
... There are about three severe, potentially fatal genetic diseases ... can rupture in pregnancy and labor or even lesser ... blood vessel surgery and other approaches can be helpful, ... when they're offered. ,Now a large follow-up ...
... University researcher says that some religious activities may promote ... take notice and help their// community deal with the ... nation of gluttony and obesity, and churches are a ... professor of sociology who has studied religion and body ...
... restore healthy glucose levels and normal insulin action in obese ... published in the August 25 issue of Science and was ... (HSPH). ,Type 2 diabetes - 90 to 95 ... million people in the United States, and causes some 200,000 ...
Cached Medicine News:Health News:Research Reveal A New Angle On Neural Circuits. 2Health News:Microcapsules target cancer cells 2Health News:Microcapsules target cancer cells 3Health News:Certification of UK Doctors Would Improve Quality of Care 2Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 2Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 3Health News:Religious Activities Could Promote Obesity 2Health News:Religious Activities Could Promote Obesity 3Health News:Religious Activities Could Promote Obesity 4Health News:Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice 2Health News:Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice 3
... monomeric contrast medium for intravascular and body ... a decade of clinical experience and use ... proven to be a valuable part of ... departments.Results from large multicentre monitoring trials1-3 confirm ...
... MultiHance (gadobenate dimeglumine) is a paramagnetic ... is complexed with gadobenate, a chelating agent ... around the godolinium ion. It is salified ... is endowed with all the physico-chemical features ...
... U.S. in 1993 to provide contrast enhancement ... detect lesions of the brain, spinal cord, ... approval for adult body and high-dose CNS ... OMNISCAN comes in different sizes to accommodate ...
... When MAGNEVIST (gadopentetate dimeglumine) injection was ... revolutionary concept of contrast-enhanced magnetic resonance imaging ... agent for use in MRI. Today, the ... indications in CNS, head, neck and body. ...
Medicine Products: